Drug recall D-0499-2026

Class II Ongoing reported May 6, 2026

Product

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.

Reason for recall

Lack of Assurance of Sterility

Lots and codes

Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.

Recall details

Recalling firm
SCOPE HEALTH, New York, NY
Distribution
Nationwide within the United States
Type
Voluntary: Firm initiated
Recall initiated
April 20, 2026

Related products